The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain

NCT06614608 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Pain

Interventions

DRUG: 5% ASKC200
DRUG: 1% ASKC200

Sponsor

Jiangsu Aosaikang Pharmaceutical Co., Ltd.